Early detection is critical to improving cancer survival rates. Too often, the limitations of today’s medical imaging technologies result in cancer being detected at late
You can also register to watch the entire Zoom webcast on-demand by clicking here
Watch Imagion CEO Bob Proulx discuss the opportunity for MagSense® Imaging on Switzer’s CEO Masterclass: Today’s imaging technologies are limited in their ability to differentiate
Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion’s technology could transform the imaging industry.
Tim Boreham profiles Imagion Biosystems in this 5-1/2 page article. Read the profile.
. Cancer treatments are most effective, and patient outcomes are improved, when tumors are detected early. Imagion Biosystems is developing the MagSense® Systems for early
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance